These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 8222188

  • 1. Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypass.
    Teoh KH, Young E, Bradley CA, Hirsh J.
    Circulation; 1993 Nov; 88(5 Pt 2):II420-5. PubMed ID: 8222188
    [Abstract] [Full Text] [Related]

  • 2. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?
    Teoh KH, Young E, Blackall MH, Roberts RS, Hirsh J.
    J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457
    [Abstract] [Full Text] [Related]

  • 3. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
    Esposito RA, Culliford AT, Colvin SB, Thomas SJ, Lackner H, Spencer FC.
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
    [Abstract] [Full Text] [Related]

  • 4. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M, Velik-Salchner C, Stalzer B, Margreiter J, Klingler A, Streif W, Fries D, Innerhofer P.
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [Abstract] [Full Text] [Related]

  • 5. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP, Haddon WS, Rothberger HK, Mills SA, Rogers AT, Bean VE, Buss DH, Prough DS, Cordell AR.
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [Abstract] [Full Text] [Related]

  • 6. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
    Guzzetta NA, Monitz HG, Fernandez JD, Fazlollah TM, Knezevic A, Miller BE.
    Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
    [Abstract] [Full Text] [Related]

  • 7. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P, Kuitunen A, Petäjä J, Ilveskero S, Lassila R.
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the non-specific binding of unfractionated heparin and low molecular weight heparin (Enoxaparin) to plasma proteins.
    Young E, Cosmi B, Weitz J, Hirsh J.
    Thromb Haemost; 1993 Oct 18; 70(4):625-30. PubMed ID: 8115988
    [Abstract] [Full Text] [Related]

  • 9. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
    Brister SJ, Ofosu FA, Buchanan MR.
    Thromb Haemost; 1993 Aug 02; 70(2):259-62. PubMed ID: 8236131
    [Abstract] [Full Text] [Related]

  • 10. Management of postoperative heparin rebound following cardiopulmonary bypass.
    Pifarré R, Babka R, Sullivan HJ, Montoya A, Bakhos M, El-Etr A.
    J Thorac Cardiovasc Surg; 1981 Mar 02; 81(3):378-81. PubMed ID: 7464201
    [Abstract] [Full Text] [Related]

  • 11. Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass.
    Ganter MT, Monn A, Tavakoli R, Klaghofer R, Zollinger A, Hofer CK.
    J Cardiothorac Vasc Anesth; 2007 Aug 02; 21(4):524-8. PubMed ID: 17678778
    [Abstract] [Full Text] [Related]

  • 12. Heparin binding to plasma proteins, an important mechanism for heparin resistance.
    Young E, Prins M, Levine MN, Hirsh J.
    Thromb Haemost; 1992 Jun 01; 67(6):639-43. PubMed ID: 1509402
    [Abstract] [Full Text] [Related]

  • 13. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
    Taneja R, Marwaha G, Sinha P, Quantz M, Stitt L, Gao R, Subramanian S, Schaus M, Keeney M, Chin-Yee I, Murkin J.
    Can J Anaesth; 2009 Jul 01; 56(7):489-96. PubMed ID: 19408066
    [Abstract] [Full Text] [Related]

  • 14. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T, Wolf HG, Sinzobahamvya N, Asfour B, Hraska V, Schindler E.
    Thorac Cardiovasc Surg; 2015 Aug 01; 63(5):397-403. PubMed ID: 26121380
    [Abstract] [Full Text] [Related]

  • 15. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB, Veerhoek D, van den Brom CE, van Barneveld LJ, Boer C.
    J Cardiothorac Vasc Anesth; 2014 Apr 01; 28(2):235-41. PubMed ID: 24342152
    [Abstract] [Full Text] [Related]

  • 16. The treatment of heparin resistance with Antithrombin III in cardiac surgery.
    Kanbak M.
    Can J Anaesth; 1999 Jun 01; 46(6):581-5. PubMed ID: 10391608
    [Abstract] [Full Text] [Related]

  • 17. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT, Monn A, Tavakoli R, Genoni M, Klaghofer R, Furrer L, Honegger H, Hofer CK.
    Eur J Cardiothorac Surg; 2006 Aug 01; 30(2):278-84. PubMed ID: 16828293
    [Abstract] [Full Text] [Related]

  • 18. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ, Joist JH, Hogue CW, Alsoufiev A, Kater K, Goodnough LT, Santoro SA, Spitznagel E, Rosenblum M, Lappas DG.
    J Thorac Cardiovasc Surg; 1995 Jul 01; 110(1):46-54. PubMed ID: 7609568
    [Abstract] [Full Text] [Related]

  • 19. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass.
    Akl BF, Vargas GM, Neal J, Robillard J, Kelly P.
    J Thorac Cardiovasc Surg; 1980 Jan 01; 79(1):97-102. PubMed ID: 7350393
    [Abstract] [Full Text] [Related]

  • 20. Comparison of two protocols for heparin neutralization by protamine after cardiopulmonary bypass.
    Arén C, Feddersen K, Rådegran K.
    J Thorac Cardiovasc Surg; 1987 Oct 01; 94(4):539-41. PubMed ID: 3309479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.